波罗类激酶4:在皮肤癌的发病过程中的分子罪祸首
Tanya Jaiswal1, Durdana Muntaqua1, Nihal Ahmad1,2
1Department of Dermatology, University of Wisconsin, Madison, WI 53705, USA.
Cells
|September 13, 2025
概括
波罗样酶4 (PLK4) 是细胞分裂的关键调节剂,也是皮肤癌治疗的有希望的标. 针对PLK4的抑制剂显示出治疗晚期和耐药性皮肤癌的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 皮肤癌是一个重大的全球健康挑战,发病率和死亡率不断增加.
- 新的治疗策略对于管理高级和耐药性皮肤癌症至关重要.
- 波罗样类激酶 (PLKs),特别是PLK4,涉及细胞循环调节和基因组稳定,使它们成为潜在的癌症标.
研究的目的:
- 审查皮肤癌中波罗样酶4 (PLK4) 的已知功能.
- 探索对PLK4在皮肤癌进展中的作用的潜在机制性见解.
- 为了确定未来研究PLK4作为皮肤癌治疗点的研究缺口.
主要方法:
- 对PLK4功能和抑制现有研究的文献综述.
- 从其他癌症类型 (如结直肠癌,甲状腺癌,淋巴瘤,白血病) 的PLK4研究中推断证据.
- 对小分子PLK4抑制剂及其临床试验结果的分析.
主要成果:
- 在包括皮肤癌在内的几种癌症中,PLK4过度表达,并调节中心重复.
- 对PLK4的失调会破坏基因组完整性,从而导致瘤发生.
- 一些PLK4抑制剂,包括CFI-400945,已经显示出临床前的疗效,CFI-400945在临床试验中显示出适度的抗癌活性.
结论:
- PLK4是皮肤癌管理的有前途的治疗标.
- 需要进一步的研究,以充分阐明PLK4在皮肤癌中的机制,并优化治疗策略.
- 单独针对PLK4或与现有治疗相结合,可能为难以治疗的皮肤癌提供新的选择.
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
